SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Biocon posts 36% growth in Biologics segment in Q1FY19

27 Jul 2018 Evaluate

Biocon has recorded a strong growth of 36% at Rs 250 crore in the Biologics segment in Q1FY19 which comprises of Novel Biologics and Biosimilars. The growth was largely driven by higher sales of biosimilar monoclonal antibodies (mAbs) in emerging markets, supported by Insulins business.

During the quarter, the company’s insulins portfolio gained market share in several emerging markets such as Malaysia, Algeria and UAE. The company’s brand Insugen, now holds a 75% share of the rh-insulin market in Malaysia.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

Biocon Share Price

383.40 2.65 (0.70%)
07-May-2026 10:27 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1835.00
Dr. Reddys Lab 1312.20
Cipla 1376.00
Zydus Lifesciences 941.60
Lupin 2475.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×